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Abstract
Primary cilia are sensory organelles that coordinate multiple cellular signaling pathways, including Hedgehog (HH), Wing-
less/Int (WNT) and Transforming Growth Factor-β (TGF-β) signaling. Similarly, primary cilia have been implicated in 
regulation of mTOR signaling, in which Tuberous Sclerosis Complex proteins 1 and 2 (TSC1/2) negatively regulate protein 
synthesis by inactivating the mTOR complex 1 (mTORC1) at energy limiting states. Here we report that TSC1 and TSC2 
regulate Smoothened (SMO)-dependent HH signaling in mouse embryonic fibroblasts (MEFs). Reduced SMO-dependent 
expression of Gli1 was demonstrated in both Tsc1−/− and Tsc2−/− cells, and we found that Tsc1 is required for TGF-β 
induced phosphorylation of SMAD2/3 and subsequent expression of the HH signaling effector and transcription factor 
GLI2. Hedgehog signaling was restored in Tsc1−/− cells after exogenous expression of Gli2, whereas rapamycin restored 
HH signaling in Tsc2−/− cells. Furthermore, we observed that Tsc1−/− MEFs display significantly elongated cilia, whereas 
cilia in Tsc2−/− MEFs were shorter than normal. The elongated cilium phenotype of Tsc1−/− MEFs is likely due to increased 
mTORC1-dependent autophagic flux observed in these cells, as both the autophagic flux and the cilia length phenotype was 
restored by rapamycin. In addition, ciliary length control in Tsc1−/− MEFs was also influenced by reduced expression of 
Gli2, which compromised expression of Wnt5a that normally promotes cilia disassembly. In summary, our results support 
distinct functions of Tsc1 and Tsc2 in cellular signaling as the two genes affect ciliary length control and HH signaling via 
different mechanisms.
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Abbreviations
HH  Hedgehog
WNT  Wingless/Int
TGF-β  Transforming growth factor-β
TSC  Tuberous sclerosis complex
MEFs  Mouse embryonic fibroblasts
4E-BP1  4E-binding protein-1
S6K1  40S ribosomal protein S6 kinase 1
PTCH1  Patched homolog 1
SMO  Smoothened
Introduction
Mutations in the tumor suppressor genes encoding TSC1 
(Hamartin) and TSC2 (Tuberin) cause a multisystemic tumor 
syndrome termed tuberous sclerosis complex (TSC). TSC is 
an autosomal dominant genetic disorder of high penetrance 
with a prevalence of 1:10,000 [1] and is characterized by 
widespread dysplastic and neoplastic lesions [2]. TSC1 and 
TSC2 were originally found to form a heterodimeric com-
plex that acts as a switch for turning off mTOR signaling 
by inactivating the mTOR complex 1 (mTORC1). Active 
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mTORC1 phosphorylates the eukaryotic initiation factor 
4E-binding protein-1 (4E-BP1) and 40S ribosomal protein 
S6 kinase 1 (S6K1) to promote protein synthesis [3, 4]. The 
phosphorylated form of 40S ribosome protein S6 is thus a 
marker for mTORC1 activity. The heterodimeric TSC com-
plex negatively regulates mTORC1 activity via the GTPase 
activity of TSC2, towards the small G-protein RHEB (Ras 
homologue enriched in brain) [5]. The mTORC1 signal-
ing cascade receives inputs from various upstream cues 
related to the metabolic and nutritional status of the cell 
and translates these into cell growth [4, 6]. In the presence 
of nutrients, mTORC1 is activated and promotes cell growth, 
including protein synthesis and energy storage. Conversely, 
during starvation mTORC1 is inhibited and autophagy is 
induced by AMP-activated protein kinase (AMPK), leading 
to generation of intracellular nutrients and energy during 
degradation of non-functional or non-essential organelles 
or protein aggregates [4, 6], in turn contributing to cell sur-
vival. During starvation AMPK promotes autophagy by 
activating ULK1 via phosphorylation at Ser317, Ser555, 
and Ser777, whereas in the presence of nutrients mTORC1 
suppresses autophagy by hampering interaction between 
AMPK and ULK1 through phosphorylation of ULK1 at 
Ser757 [7]. In addition, the TSC complex activates mTOR 
complex 2 (mTORC2) [8], which regulates the cytoskel-
eton through its stimulation of F-actin stress fibers and Rho 
GTPases [9]. TSC1 and TSC2 also play a role in regulating 
pathways other than mTORC1/2. For example, TSC inac-
tivation has been shown to cooperate with non-canonical 
Smoothened (SMO)-independent Hedgehog (HH) signaling 
to drive tumor growth in murine cerebellar granule neuron 
precursors [10]. Furthermore, TSC1 was demonstrated to 
be required for the proper activation of the transforming 
growth factor-β (TGF-β)-SMAD2/3 pathway in HeLa cells 
[11]. Despite these advances, the roles of TSC1 and TSC2 in 
regulating signaling pathways independently of mTORC1/2 
remain poorly understood.
Primary cilia are microtubule-based sensory organelles 
that emanate from the centrosomal mother centriole/basal 
body at the surface of many quiescent vertebrate cell types 
[12]. These cilia play critical roles in the coordination of 
multiple cellular signaling pathways, which are regulated 
by diverse chemical, physical, and morphogenetic cues 
during development and in tissue homeostasis [13, 14]. 
Defects in ciliary assembly, maintenance, and function are, 
therefore, associated with severe developmental defects and 
diseases, known as ciliopathies, which include congenital 
heart defects, skeletal dysplasia, renal diseases, cerebral 
anomalies, obesity, tumorigenesis, and cancer [12, 15–19]. 
The cellular signaling systems that are operated by primary 
cilia include HH [20, 21], Wingless/Int (WNT) [22–24], 
platelet-derived growth factor receptor alpha (PDGFR-α) 
[25–27], TGF-β [28, 29], Notch [30], Hippo [31], and 
mTOR signaling [32, 33]. Recent studies have also indicated 
a functional connection between autophagy and ciliogenesis 
and/or cilia-coordinated signaling, but there is currently no 
consensus on whether increased autophagy leads to longer 
or shorter cilia [34, 35].
The vertebrate HH signaling pathway is one of the best 
studied ciliary signaling pathways and is essential for embry-
onic development and the maintenance of multiple organs 
[36, 37]. The 12-pass transmembrane receptor patched 
homolog 1 (PTCH1) is localized to the ciliary membrane in 
the absence of HH and prevents ciliary localization of SMO, 
a class F, G-protein coupled receptor that is required for the 
activation of GLI transcription factors. In this “OFF” stage, 
GLI2 and GLI3 are proteolytically cleaved to form repres-
sor forms (GLI-R), which block transcriptional activation of 
target genes in HH signaling. The binding of HH to PTCH1 
induces ciliary exit of PTCH1 causing concomitant cili-
ary enrichment of SMO, which results in decreased ciliary 
cAMP production, and in stabilization of full-length forms 
of GLI2 and GLI3 (GLI2-FL and GLI3-FL) in the cilium 
followed by translocation of these proteins to the nucleus 
in their activated forms (GLI2-A and GLI3-A) to induce 
transcriptional activation of target genes, including Gli1 and 
Ptch1 [38–42].
Compared to HH signaling, less is known about the 
role of primary cilia in mTOR signaling. TSC1 was shown 
to localize to the base of the cilium [43], and its loss in 
zebrafish was associated with left–right asymmetry defects 
in addition to ciliary elongation [33]. An aberrant cilia 
phenotype was also reported in murine cells where loss-of-
function mutations in either Tsc1 or Tsc2 induced elongation 
of primary cilia [43, 44]. In addition, primary cilia were 
shown to regulate mTORC1 activity through the LKB1-
AMPK pathway in murine kidney cells [32]. While the het-
erodimeric TSC1-TSC2 complex plays a crucial regulatory 
role in mTORC1 activity, the need to evaluate the separate 
functions of TSC1 and TSC2 is evident. Although evidence 
supports the interdependence of TSC1 and TSC2 in the 
regulation of mTORC1 [45], more than 50 proteins have 
been reported to interact with TSC1 and/or TSC2 [46], sug-
gesting that both proteins function in other cellular contexts 
independent of each other.
Here we report that both Tsc1−/− and Tsc2−/− mouse 
embryonic fibroblasts (MEFs) affect ciliary length control 
and cellular signaling pathways, but via different mecha-
nisms. First, we found that Tsc1−/− cells exhibited elongated 
cilia, which we show is due to dysregulated autophagy and 
mTORC1 activity as well as reduced GLI2-mediated expres-
sion of Wnt5a. In contrast, we observed significantly short-
ened cilia in Tsc2−/− cells. Second, while both Tsc1−/− and 
Tsc2−/− MEFs display impaired SMO-dependent HH sign-
aling, TSC2 affects HH signaling via mTORC1, whereas 
TSC1 regulates HH signaling via the TGF-β-SMAD2/3 
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pathway, which in turn regulates expression of the GLI2 
transcription factor required for HH target gene expression. 
Collectively, our results indicate that TSC1 and TSC2 affect 
ciliary length control and canonical HH signaling via differ-
ent mechanisms.
Results
Primary cilia are elongated and shortened in Tsc1−/− 
and Tsc2−/− MEFs, respectively
At low nutrient levels, the TSC1-TSC2 complex downregu-
lates mTORC1 activity so that the loss of either protein is 
associated with constitutive activation of mTOR signal-
ing [47, 48]. To confirm this, Tsc1−/− and Tsc2−/− MEFs 
were starved (0.5% fetal bovine serum, FBS) for 48 h and 
analyzed by SDS-PAGE and western blotting (WB) for 
the expression of Tsc1 and Tsc2, and the phosphorylation 
status of S6 (pS6), which is a marker for mTORC1 activ-
ity (Fig. 1a). As expected, TSC1 and TSC2 were absent in 
Tsc1−/− and Tsc2−/− MEFs, respectively. It has previously 
been demonstrated that TSC1 stabilizes TSC2 by protect-
ing TSC2 from ubiquitination and proteosomal degradation 
[49]. This concurs with the lower level of TSC2 observed in 
Tsc1−/− MEFs (Fig. 1a). Furthermore, phosphorylation of 
S6 (pS6) was detectable in both Tsc1−/− and Tsc2−/− MEFs 
upon serum depletion, demonstrating constitutive mTORC1 
activity. This activity was hampered by treatment with the 
mTORC1 inhibitor, rapamycin, verifying that phosphoryla-
tion of S6 is mTORC1-dependent (Fig. 1a).
Next, we evaluated the consequence of TSC1 and TSC2 
depletion on the frequency and length of primary cilia dur-
ing serum starvation. To this end, Tsc1−/− and Tsc2−/− MEFs 
were serum starved (0.5% FBS) for 48 h to induce growth 
arrest and formation of primary cilia, and subsequently ana-
lyzed by immunofluorescence microscopy (IFM) with anti-
bodies against γ-tubulin that marks the ciliary base, acety-
lated α-tubulin that marks the cilium, and IFT88, which is 
component of the intraflagellar transport system and marks 
both the ciliary base and the cilium (Fig. 1b). While the fre-
quency of ciliated cells appeared to be unaffected by deple-
tion of either TSC1 or TSC2 (wild type (WT): 53.6 ± 10.4; 
Tsc1−/−: 56.6 ± 2.3; Tsc2−/−: 60.7 ± 5.9), we found that 
cilia in Tsc1−/− MEFs were significantly longer with an 
average length of 2.98 μm as compared to WT MEFs that 
displayed an average ciliary length of 2.20 μm (Fig. 1b, c), 
which is in accordance with previous observations [43]. 
In contrast, we observed that the length of primary cilia 
in Tsc2−/− cells was significantly decreased with a mean 
length of 0.74 μm (Fig. 1c). The observed ciliary length 
phenotypes of the mutant cells were not an indirect effect of 
increased cell size [50], since microscopic analysis showed 
that the sizes of mutant and wild type cells were largely 
similar (Fig. 1d). Furthermore, the ciliary length phenotype 
of the Tsc1−/− MEFs did not seem to be secondary to cell 
cycle defects, as judged by staining with antibody against 
acetylated tubulin and KI67, a potent proliferation marker; 
primary cilia were only induced in quiescent cells and re-
addition of serum lead to cell cycle re-entrance as expected 
(Fig. 2a).
We then asked if exogenous expression of TSC1 
and TSC2 could rescue the ciliary length phenotype of 
Tsc1−/− and Tsc2−/− cells. While transfection with TSC1-
encoding plasmid (pTSC1) partly restored the ciliary length 
in Tsc1−/− cells, only minor effect was observed by transfec-
tion of Tsc2−/− cells with TSC2-encoding plasmid (pTSC2) 
(Supplementary Figure 1a, b). The latter result could be due 
to a toxic effect of the transfection and/or aberrant produc-
tion of a smaller protein product (Supplementary Figure 1c, 
d). The transfection efficiency, measured by transfection 
with pGFP plasmid, is 14–15% (Supplementary Figure 1e). 
As an alternative approach to confirm the ciliary length phe-
notypes of the Tsc1−/− and Tsc2−/− cells, we used siRNA 
to deplete TSC1 or TSC2 from WT MEFs (Fig. 2b). Using 
this approach, we found that the siRNA-depleted WT cells 
displayed similar ciliary lengths as observed in Tsc1−/− and 
Tsc2−/− cells, respectively (Fig. 2c, d), confirming the mutant 
cell phenotypes. To test the dominancy of the two genes, 
we furthermore subjected Tsc1−/− cells to siRNA-mediated 
depletion of TSC2, and vice versa (Fig. 2e; Supplementary 
Figure 2). In both cases, a reduction in the ciliary length was 
observed, indicating that the absence of Tsc2 is dominant for 
the resulting phenotype (Fig. 2f).
Finally, we induced cilia formation in starvation medium 
(0.5% FBS) in combination with rapamycin and found that 
the ciliary length phenotype of Tsc1−/− MEFs was rescued 
by this treatment, while rapamycin had no observable effect 
on the ciliary length in Tsc2−/− MEFs (Fig. 2g). These 
results support the conclusion that the increased ciliary 
length in Tsc1−/− MEFs is associated with aberrant activity 
of mTORC1. Consistent with Hartman et al. [43], the cili-
ation frequency in WT, Tsc1−/− and, Tsc2−/− cells did not 
appear to be affected by rapamycin.
Tsc1−/− MEFs exhibit increased mTORC1‑dependent 
autophagy
Several studies have shown that autophagy regulates ciliary 
length [34, 35, 51–55]. To test for differences in autophagic 
activity between Tsc1−/− and Tsc2−/− MEFs, we performed 
an autophagic flux assay, measuring the net flux of LC3B-
II in starvation medium (0.5% FBS), stimulating both 
autophagy and formation of primary cilia (Fig. 3a). LC3B 
is expressed as a pro-LC3B protein, which is subsequently 
cleaved by removing the C terminus to produce the cytosolic 
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form, LC3B-I. The cytosolic form is conjugated with phos-
phatidylethanolamine to form the membrane-bound LC3B-
II, which is attached to the autophagosome membrane 
reflecting maturation of the autophagosomes. After fusion of 
the autophagosomes with lysosomes, LC3B-II is degraded or 
released as LC3B-I through delipidation. Turnover of LC3-II 
thus reflects the autophagic activity [35]. The net flux and the 
amount of LC3B-I and LC3B-II were significantly increased 
in the Tsc1−/− cells compared to the WT and Tsc2−/− cells 
(Fig. 3b–d). As the cilia length in Tsc1−/− cells was reduced 
in the presence of rapamycin (Fig. 2g), we investigated the 
effect of rapamycin on autophagy. Rapamycin reduced the 
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net flux, and the amount of LC3B-I and LC3B-II in the 
Tsc1−/− cells to levels comparable to that of WT cells. No 
effect of rapamycin on LC3B was observed for the WT or 
the Tsc2−/− cells (Fig. 3a–d). This indicates that the long 
cilia phenotype in Tsc1−/− cells may be a result of increased 
net flux. Compared to Tsc2−/− and WT cells, Tsc1−/− cells 
seem to contain larger amounts of LC3B protein. Recalcu-
lating the efflux relative to the amount of LC3B-I elimi-
nated the difference between the cell lines and the effect of 
rapamycin on the Tsc1−/− cells (legend Fig. 3d). Thus, the 
increased amount of LC3B-II in Tsc1−/− cells correlates with 
the increased LC3B-I level.
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To test the effect of the autophagic activity on the cili-
ary length more directly, we investigated the ciliary length 
in the Tsc1−/− cells after treatment with lysosomal protease 
inhibitors for 4 h to inhibit autophagy, and found a profound 
reduction (Fig. 3e, f). However, a significant reduction in the 
ciliary length in both the Tsc2−/− and the WT cells was also 
observed (Fig. 3f). In contrast, treatment with the autophagy 
inducer ABT-737 [56] strongly induced ciliary elongation 
in the Tsc1−/− cells, whereas no effect was observed in the 
WT cells (Fig. 3g, h). In summary, these results indicate 
that autophagy initiated by serum starvation is important 
for the growth of the primary cilium in general, whereas 
increased autophagy specifically causes ciliary lengthening 
in the Tsc1−/− cells.
Tsc1−/− and Tsc2−/− MEFs display impaired 
SMO‑dependent HH signaling
Some evidence points to a possible link between the HH 
and mTOR signaling, since a combination therapy inhibit-
ing both pathways results in an enhanced therapeutic effect 
compared to inhibiting either pathway alone [57]. There-
fore, we speculated whether HH signaling is altered in 
Tsc1−/− and Tsc2−/− MEFs. To monitor HH signaling, we 
initially performed quantitative RT-PCR (qPCR) analy-
sis of the expression of the HH target genes, Gli1 and 
Ptch1 in cells starved (0.5% FBS) for 48 h to induce cilia 
formation. To activate canonical HH signaling, the SMO 
agonist purmorphamine [58] was added for the last 24 h of 
cultivation. Furthermore, cells were cultured in the pres-
ence and in the absence of rapamycin to evaluate the role 
of mTORC1 in purmorphamine-induced expression of 
the target genes. As shown (Fig. 4a, b), purmorphamine-
induced expressions of Gli1 and Ptch1 were significantly 
reduced in both Tsc1−/− and Tsc2−/− MEFs as compared 
to WT cells. However, rapamycin treatment restored the 
mRNA levels to WT levels only in Tsc2−/− MEFs, indi-
cating that defects in HH signaling are associated with 
increased mTORC1 activity in Tsc2−/− MEFs. Since 
rapamycin treatment abrogated the elongated cilia phe-
notype observed in Tsc1−/− MEFs (Fig. 2g), we further 
conclude that the long cilia phenotype observed in these 
cells (Fig. 1) is not directly caused by aberrant HH signal-
ing or vice versa.
To further investigate the mechanisms by which HH 
signaling is impaired in Tsc1−/− and Tsc2−/− MEFs, we 
then performed qPCR analysis of the mRNA levels of Gli2 
and Gli3, which are generally constitutively expressed in 
normal cells [59, 60]. In these experiments, we observed 
that the expression of Gli2, but not Gli3, is greatly 
reduced in Tsc1−/− cells, both in the presence and absence 
of purmorphamine and rapamycin (Fig. 4c, d). Cellular 
fractionation and WB analysis confirmed the absence of 
detectable GLI2 in the nucleus of Tsc1−/− cells (Supple-
mentary Figure 3). This indicates that reduced expression 
of Gli1 and Ptch1 may be caused by the lack of a suf-
ficient level of activator forms of GLI2 independent of 
mTORC1 activity. In contrast, Tsc2−/− MEFs displayed 
normal expression levels of both Gli2 mRNA and Gli3 
mRNA compared to WT cells (Fig. 4c, d). To determine 
whether decreased HH signaling in Tsc1−/− MEFs can be 
explained by the loss of GLI2, we examined HH signaling 
in Tsc1−/− MEFs in which a plasmid expressing GLI2 was 
introduced. In agreement with our hypothesis, exogenous 
expression of Gli2 caused significantly elevated expression 
of Gli1 in response to purmorphamine treatment in these 
cells (Fig. 4e; Supplementary Figure 4). We also evalu-
ated the level of Gli2 mRNA in Tsc1−/− MEFs subjected 
to exogenous expression of TSC1, by transfecting the cells 
with the pTSC1 plasmid. In this case, we observed a ~ ten-
fold increase in the level of Gli2 transcript, establishing 
a direct link between TSC1 and Gli2 expression (Fig. 4f; 
Supplementary Figure 5). Finally, inhibition of mTORC1 
activity by rapamycin did not affect the purmorphamine-
induced increase in Gli1 expression in Tsc1−/− MEFs even 
after introducing exogenous Gli2 (Fig. 4e). This indicates 
that TSC1 regulates HH signaling through the expression 
of Gli2 and this regulation is independent of mTORC1 
activity.
Fig. 3  Loss of Tsc1 leads to increased mTORC1-dependent 
autophagic activity. a SDS-PAGE and WB analyses on the level of 
LC3B and phosphoS6 (pS6) in WT, Tsc1−/− and Tsc2−/− MEFs 
starved (0.5% FBS) for 48 h in the absence or presence of rapamycin 
(Rapa) (24 h) followed by treatment with lysosomal protease inhibi-
tors (PI) as indicated. α-tubulin (α-TUB) was used as loading control. 
b Normalized LC3B-II flux for experiments shown in a as measured 
by the LC3B-II protein levels after 2  h PI treatment subtracted the 
protein levels at 0 h. c Normalized LC3B-I protein levels for experi-
ments shown in a before PI treatment. d Normalized LC3B-II protein 
levels for experiments shown in a before PI treatment. b–d Quantifi-
cations of LC3B-I/II protein levels were performed by densitometric 
analysis and normalized to α-TUB, and to a control sample loaded on 
all gels to correct for blotting efficiency. Error bars represent SEM 
(n = 3). Recalculating of the LC3B-II flux relative to the amount of 
LC3B-I eliminated the difference between the cell lines and the effect 
of rapamycin on the Tsc1−/− cells (WT: 0.506 ± 0.087/0.584 ± 0.864; 
Tsc1−/−: 0.6261  ±  0.314/0.864  ±  0.443; Tsc2−/−: 
0.673  ±  0.253/0.662  ±  0.314. No statistic significant differences 
were obtained). e IFM analysis of primary cilia labeled with anti-γ-
tubulin (γ-TUB) antibody in WT, Tsc1−/− and Tsc2−/− MEFs after 
4 h PI treatment. Scale bar: 5 µM. f Quantification of ciliary lengths 
for experiment shown in e. One hundred cilia from three independ-
ent experiments were used for quantification; error bars represent 
SEM. g IFM analysis of primary cilia labeled with γ-TUB antibody 
in serum-deprived (48 h) WT and Tsc1−/− MEFs in the presence and 
in the absence of the autophagy inducer ABT-737. Scale bar: 5 µM. h 
Quantification of ciliary lengths for experiment shown in g. One hun-
dred cilia from two independent experiments were used for quantifi-
cation; error bars represent SEM
◂
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TSC1 regulates HH signaling 
via a TGF‑β‑SMAD2/3‑dependent pathway
Previous studies have shown that primary cilia in fibroblasts 
coordinate canonical TGF-β signaling through clathrin-
dependent endocytosis of activated receptors at the cili-
ary pocket followed by phosphorylation and activation of 
SMAD2/3 transcription factors in early endosomes around 
the ciliary base region [28]. Activated SMAD2/3 then forms 
a heterotrimeric complex with SMAD4, which translocates 
to the nucleus for expression of target genes. Interestingly, 
several reports have indicated that GLI2 is a target gene for 
SMAD2/3 signaling in various human cell lines including 
fibroblasts [61, 62], and it has recently been shown that 
TSC1, independently of TSC2, is required for the association 
between TGF-β receptors and SMAD2/3, so that the knock-
down of TSC1 causes an impaired phosphorylation and 
nuclear translocation of SMAD2/3 in HeLa cells [11]. We 
therefore speculated whether canonical TGF-β signaling is 
impaired in Tsc1−/− MEFs, leading to a reduced expression 
of Gli2. To address this, we investigated SMAD2/3 phos-
phorylation in response to TGF-β1 stimulation. In contrast to 
WT and Tsc2−/− MEFs, SMAD2/3 phosphorylation was sig-
nificantly reduced in Tsc1−/− MEFs after 1 h of stimulation 
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Fig. 4  Loss of Tsc1 or Tsc2 is associated with impaired HH signal-
ing. a–d WT, Tsc1−/− and Tsc2−/− MEFs were starved (0.5% FBS) 
for 48 h to induce cilia formation in the presence or absence of rapa-
mycin. Purmorphamine (5 µM) was administered to the medium for 
the final 24 h to stimulate HH signaling before mRNA isolation and 
qPCR analysis. Expression profiles of the target genes were normal-
ized to the amount of endogenous Tbp mRNA. Normalized expres-
sion profiles of a Gli1, b Ptch1. Error bars represent SEM (n = 5). 
Normalized expression profiles of c  Gli2 and d  Gli3. e Normalized 
expression profiles of Gli1 in Tsc1−/− MEFs transfected with 2  µg 
plasmid (pMock (empty vector) or pGli2) and cultured in starvation 
medium (0.5% FBS) for 48 h (24 h after transfection) with purmor-
phamine administration (for the last 24  h), as indicated. Error bars 
represent SEM (n = 3). The reduced signal in e compared to a might 
be due to transfection (pMock included) of the cells. f Normalized 
expression profiles of Gli2 in Tsc1−/− MEFs transfected with 1  µg 
plasmid (pMock or pTSC1) and starved (0.5% serum) for 48 h (24 h 
after transfection). Error bars represent SEM (n = 3)
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with TGF-β1 (Fig. 5a), showing that TSC1, but not TSC2, 
is required for activation of canonical TGF-β signaling, as 
previously observed in HeLa cells [11].
To further examine whether the loss of TSC1 merely 
results in a delayed response to TGF-β1 stimulation, 
we evaluated the level of SMAD2/3 phosphorylation in 
Tsc1−/− MEFs after 1, 6, 12, and 24 h of ligand treatment. 
These experiments showed that SMAD2/3 phosphorylation 
is reduced at all investigated time points (Fig. 5b, c), thereby 
substantiates the conclusion that TSC1 plays a critical role in 
the activation of SMAD2/3. No SMAD2/3 phosphorylation 
could be observed after 24 h (Fig. 5b) in agreement with 
a previous study showing that SMAD2/3 phosphorylation 
peaks after 1 h of ligand exposure, and declines over the next 
8 h, to finally cease [63].
To investigate a potential relationship between impaired 
Gli2 expression and SMAD2/3 phosphorylation in 
Tsc1−/− MEFs, we carried out qPCR analysis on Gli2 expres-
sion in response to TGF-β1 stimulation in these cells. Inter-
estingly, an increase in Gli2 expression was evident in WT 
MEFs for at least 6 h while no response in Tsc1−/− MEFs 
was observed during this time interval (Fig. 5d). As a control 
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Fig. 5  Tsc1−/− cells display impaired TGF-β-SMAD2/3 signaling. 
a SDS-PAGE and WB analyses of WT, Tcs1−/− and Tsc2−/− MEFs 
serum starved (0.5% serum) for 48 h to induce cilia formation in the 
presence or absence of TGF-β1 for 45 min. Antibodies against TSC2, 
phospho-SMAD2/3 (pSMAD2/3) and SMAD2/3 were used as indi-
cated. GAPDH was used as loading control. b SDS-PAGE and WB 
analyses of WT and Tsc1−/− MEFs serum starved for 48 h in the pres-
ence of TGF-β1 for the indicated time points. c Quantification of rela-
tive levels of pSMAD2/3 normalized to total SMAD2/3 for experi-
ment shown in b. Error bars represent SEM (n = 3). d Normalized 
expression profiles of Gli2 mRNA in WT and Tsc1−/− MEFs cultured 
to confluence in complete medium and subjected to TGF-β1 stimu-
lation for the indicated time points before RNA isolation and qPCR. 
Error bars represent SEM (n = 3). e SDS-PAGE and WB analyses of 
WT MEFs cultured in serum deprived (0.5% FBS, 48 h) in the pres-
ence or absence of TGF-β1 and SB431542 for 45 min. f Normalized 
expression profiles of Gli2 mRNA in WT MEFs cultured in com-
plete medium and subjected to TGF-β1 in the presence or absence 
of SB431542 for the indicated time points. Error bars represent SEM 
(n = 3). Expression profiles of Gli2 were normalized to endogenous 
Tbp mRNA
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for ligand specificity in receptor-mediated SMAD2/3 phos-
phorylation and requirement for TGF-β signaling in Gli2 
expression, SDS-PAGE, WB and qPCR analyses showed 
that administration of the TGF-β receptor antagonist, 
SB431542 [64], abolished SMAD2/3 phosphorylation 
(Fig. 5e) and greatly reduced the expression of Gli2 in WT 
MEFs (Fig. 5f).
Reduced Gli2 expression affects Wnt5a expression 
resulting in elongated cilia in Tsc1−/− MEFs
The prominent differences in the lengths of primary cilia in 
Tsc1−/− and Tsc2−/− MEFs (Fig. 1b, c) suggest that signal-
ing defects in these cells may also have an impact on ciliary 
length control. Both TGF-β and HH signaling have been 
shown to regulate the expression of the gene encoding the 
non-canonical WNT ligand, WNT5A [65–67], which is 
known to control ciliary length by inducing disassembly of 
the primary cilium [65, 66, 68, 69]. We therefore hypoth-
esized that Wnt5a expression in Tsc1−/− MEFs is compro-
mised as a result of low Gli2 expression. To investigate this, 
growth-arrested ciliated cells were subjected to re-addition 
of serum for different times to monitor the expression of 
Wnt5a by qPCR analysis during ciliary disassembly and 
cell cycle re-entry. As shown in Fig. 6a, the level of Wnt5a 
mRNA was clearly detected in WT and Tsc2−/− MEFs, but 
almost undetectable in Tsc1−/− MEFs (Fig. 6a), in agree-
ment with our hypothesis. As Wnt5a has been shown also 
to be regulated by GLI3 [65], we furthermore investigated 
the GLI3-FL/GLI3-R ratio in WT and Tsc1−/− MEFs before 
and after purmorphamine stimulation. Whereas a significant 
increase in the GLI3-FL/GLI3-R ratio could be observed 
in the WT MEFs as an effect of the purmorphamine stimu-
lation, indicating higher amount of active GLI3, no effect 
could be observed in the and Tsc1−/− cells (Supplementary 
Figure 3). Therefore, we cannot exclude that reduced for-
mation GLI3-FL in conjunction with low levels of GLI2 is 
involved in the reduced amount of Wnt5a mRNA observed 
in the Tsc1−/− MEFs.
To further investigate the relationship between the expres-
sion of Gli2 and Wnt5a, we transfected Tsc1−/− MEFs with 
the GLI2-encoding plasmid and found an increased expres-
sion of Wnt5a (Fig. 6b, Supplementary Figure 4). Indeed, 
stimulation with recombinant WNT5a restored the length of 
cilia in Tsc1−/− MEFs to a level comparable to that of WT 
cells (Fig. 6c, d), supporting the conclusion that reduced 
expression of Wnt5a contribute to the elongated cilia phe-
notype of Tsc1−/− MEFs. To confirm this observation, we 
used siRNA to knock down Wnt5a in WT MEFs and subse-
quently measured ciliary length after culturing the cells for 
24 h in starvation medium (0.5% FBS). An increased ciliary 
length was observed, compared to cells transfected with an 
siRNA construct containing a scramble sequence (Fig. 6e, 
f; Supplementary Figure 6), confirming that the expression 
of Wnt5a promotes ciliary shortening. Moreover, siRNA-
mediated knock down of Gli2 in WT MEFs (Fig. 6g; Sup-
plementary Figure 7) lead to ciliary lengthening (Fig. 6h), 
supporting that Wnt5a expression depends on GLI2.
It is possible that other factors than GLI2, including 
GLI3, may be involved in regulation of Wnt5a expression 
as elevated Wnt5a expression was observed in Tsc2−/− MEFs 
(Fig. 6a), which is consistent with their short cilia pheno-
type, although the level of Gli2 mRNA in Tsc2−/− MEFs was 
comparable to the level in WT cells (Fig. 4c).
Discussion
The heterodimeric TSC complex that consists of TSC1 
(Hamartin) and TSC2 (Tuberin) plays a critical role in coor-
dinating extracellular signals with intracellular energy status 
to control cell proliferation and growth [48]. However, the 
independent functions of the two TSC proteins are less well 
known. In this study, we investigated the cilia phenotypes in 
MEFs lacking either TSC1 or TSC2. While our observation 
of elongated cilia in Tsc1−/− MEFs is in accordance with 
previous results [33, 43, 44], our observations of reduced 
ciliary length in Tsc2−/− are not [43]. In a previous study 
performed by Hartman et al. [43], it was found that the cilia 
in both Tsc1−/− and Tsc2−/− MEFs were 17–27% longer 
than WT cilia resulting in the average length of 1.54 µm 
in Tsc1−/− cells and 1.40 µm in Tsc2−/− cells, respectively 
[43]; in both cases, shorter than the average cilia length of 
2.7 µm measured in our WT cells. The reason for this dis-
crepancy is unknown. Hartman et al. cultured the cells for 
48 h completely without serum [43], but in our system, we 
were not able to obtain viable cells under these conditions. 
We confirmed our results by demonstrating similar cilia 
phenotypes in cells subjected to siRNA-mediated knock 
down of Tsc1 and Tsc2, respectively. In addition, whereas 
Hartman et al. [43] found that the length of the cilia was 
insensitive to rapamycin treatment, we found that inhibition 
of mTORC1 activity abrogated the long cilia phenotype in 
Tsc1−/− MEFs. That loss of TSC1 causes elongated cilia in a 
rapamycin-sensitive manner has previously been reported in 
Tsc1 conditional knockout distal convoluted tubules in mice 
[44], and in Danio rerio (zebrafish) [33, 51].
Increased mTORC1 activity was observed in both the 
Tsc2−/− and Tsc1−/− cells, as expected, due to lack of inhibi-
tion of mTORCI. It is also generally accepted that increased 
mTORC1 activity is associated with reduced autophagy [47, 
48], but surprisingly we observed that loss of Tsc1 led to 
increased autophagic flux, and both increased mTORC1 
activity and increased autophagy was inhibited by rapa-
mycin treatment. The increased autophagic flux in the 
Tsc1−/− cells correlated with an increased level of LC3B, 
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Fig. 6  Cilia elongation in Tsc1−/− cells is partly abrogated by WNT5a 
administration. a Normalized expression profiles of Wnt5a mRNA in 
WT, Tsc1−/− and Tsc2−/− MEFs starved (0.5% FBS) for 48 h followed 
by serum re-stimulation (10% FBS) for the indicated time points. 
Error bars represent SEM (n = 3). b Normalized expression profiles 
of Wnt5a mRNA in Tsc1−/− MEFs transfected with 1  µg plasmid 
(pMock (empty vector) or pGli2) and cultured in complete medium 
for 48 h before RNA isolation and qPCR. Error bars represent SEM 
(n = 3). a, b Expression profiles of Wnt5a were normalized to endog-
enous Tbp mRNA. c IFM analysis of primary cilia in Tsc1−/− MEFs 
serum deprived for 48 h in the presence and in the absence of recom-
binant WNT5A. Cilia were labeled with anti-acetylated α-tubulin 
(Ac-TUB) antibodies. Nuclei were visualized with DAPI staining. d 
Quantification of ciliary lengths for experiment shown in c. One hun-
dred cilia from three independent experiments were used for quantifi-
cation; error bars represent SEM (n = 3). e IFM analysis of primary 
cilia in WT MEFs transfected with either siScramble or siWnt5a for 
24  h followed by serum deprivation for 48  h before analysis. Cilia 
were labeled with Ac-TUB antibody and the ciliary base/centro-
some was labeled with anti-γ-tubulin (γ-TUB) antibody. Nuclei were 
visualized with DAPI staining. f Quantification of ciliary lengths for 
experiment shown in e. Three hundred cilia from three independent 
experiments were used for quantification; error bars represent SEM. 
g IFM analysis of primary cilia (Ac-TUB) in WT MEFs transfected 
with either siScramble or siGli2 for 24 h followed by serum depriva-
tion for 48 h before analysis. Nuclei were visualized with DAPI stain-
ing. h Quantification of ciliary lengths for experiment shown in g. 
Two hundred cilia from three independent experiments were used for 
quantification; error bars represent SEM. Scale bars (c, e, g): 5 µM
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which may indicate increased autophagy as it has been 
shown that starvation leads to fast conversion of LC3B-I to 
LC3B-II (after 15–30 min) and to increased expression of 
LC3B after long time starvation [70]. In line with a recent 
study in mouse bone marrow macrophages [71], we also 
found that loss of Tsc1 in MEFs leads to increased amount 
of LC3B protein, which can be normalized by rapamycin. In 
addition, Tsc1−/− macrophages dispalyed  increased number 
of autophagosomes, activation of AMPK, phosphorylation 
of ULK1 (site Ser555), and increased amount of Beclin1 
protein, all observations supporting increased autophagic 
activity in the Tsc1−/− cells [71].
Several studies have shown that autophagy regulates cilia 
length [34, 35, 51–55], but with disagreement about whether 
increased autophagy leads to longer or shorter cilia. Three 
different studies [52, 53, 55] demonstrated that cigarette 
smoke, flavonoid silibinin and the anti-malaria medicine 
mefloquine lead to increased autophagy. However, whereas 
cigarette smoke and silibinin treatments was associated 
with  shortening of cilia in mouse lung tissue and embryonic 
preadipocytes [52, 55], cilia were elongated as an effect of 
mefloquine treatment in RPE cells [53]. Furthermore, the 
effect of Atg5, a gene essential for autophagy, was investi-
gated in three other studies, with different outcomes [34, 35, 
54]. Whereas longer cilia were observed in mutant MEFs in 
one study [35], shorter and reduced number of cilia were 
observed in two other studies in Atg5 mutant MEFs and mice 
kidney proximal tubular cells, respectively [34, 54], indicat-
ing that autophagy induces cilia growth, in agreement with 
our results.
Further, our data show that treatment with lysosomal pro-
tease inhibitors reduces the ciliary length in both WT and 
mutant MEFs, and treatment with the autophagy inducer 
ABT-737 leads to cilia elongation in Tsc1−/− cells. These 
observations indicate that nutrient deprivation-induced 
ciliogenesis depends on proteins delivered by autophagy. 
Furthermore, the rapamycin-sensitive long cilia phenotype 
observed in Tsc1−/− cells indicates that active mTORC1 
in these cells is a prerequisite for increased cilium elonga-
tion. This result is in agreement with previous observations 
of cilia in Kupffer’s vesicle (ciliated epithelial organ) of 
Tsc1−/− zebrafish, where rapamycin treatment was shown 
to cause cilia shortening and overexpression of S6K1 led to 
ciliary lengthening [51].
As a result of low energy stress due to the constitutive 
mTORC1 activation in Tsc1−/− and Tsc2−/− cells, it is pos-
sible that AMPK is activated. AMPK induces autophagy, 
directly through phosphorylation of ULK1 (Ser555) and 
indirectly through phosphorylation of TSC2, which then 
inhibits mTORC1 [7]. The increased autophagic activity 
in Tsc1−/− relative to Tsc2−/−cells might be due to the lack 
of TSC2 in Tsc2−/− cells. The reduced autophagic activity 
in WT cells compared to Tsc1−/− cells might be due to an 
intact TSC1/TSC2 complex in WT cells capable of keep-
ing the mTOR activity under control, preventing overuse 
of resources. Thus, the increased level of autophagy in 
Tsc1−/− cells compared to WT cells might be a result of 
constitutive mTORC1 activation, which in turn may pro-
mote ciliary extension, in agreement with the observed cili-
ary lengthening in the Tsc1−/− cells, but not in WT cells, as 
a result of ABT-737-induced autophagy. Alternatively, the 
observed increased autophagy in Tsc1−/− cells could be due 
to a yet unknown TSC1-dependent mechanism on autophagy 
(Fig. 7).
While few studies have focused on cross-talk between 
HH and mTORC1 signaling, the progression of epithelial 
to mesenchymal transition, which marks the potential inva-
siveness and metastatic potential of tumors, was shown 
to be diminished by rapamycin in a xenograft model of 
rhabdomyosarcoma in a manner that not only inhibited 
mTORC1 activity but also HH signaling [72]. Furthermore, 
a cross-talk between the two pathways has been described 
in a model of esophageal cancer where mTORC1/S6K1 
promotes the oncogenic function of GLI1, through S6K1-
mediated phosphorylation of GLI1, in a SMO-independent 
manner [57]. We here show that TSC1 and TSC2 via differ-
ent mechanisms play critical roles in activation of canonical, 
SMO-dependent HH signaling adding further complexity 
to the role of mTOR signaling components in coordinating 
diverse HH pathways. In both Tsc1−/− and Tsc2−/− MEFs, 
the levels of Gli1 and Ptch1 expression in purmorphamine-
stimulated cells were greatly reduced as compared to WT 
cells, but the ability to respond to purmorphamine was to a 
large degree restored by rapamycin only in Tsc2−/− MEFs. 
These results suggest that the activation of canonical HH 
signaling relies on the inhibition of mTORC1 activity in 
a TSC2-dependent manner, while TSC1 largely operates 
through mTORC1-independent pathway(s) to ensure robust 
HH signaling in response to activation of SMO. Indeed, we 
demonstrate that impaired HH signaling in Tsc1−/− MEFs, is 
due to low expression of Gli2, likely as a result of impaired 
TGF-β-SMAD2/3 signaling (Fig. 5a). This is in line with 
previous work showing that SMAD2/3 activation is impaired 
in Tsc1−/− but not in Tsc2−/− cells [11].
It is important to address the question of how and where 
TSC1 contributes to proper TGF-β signaling. We did not 
investigate expression levels and the cellular localization of 
TGF-β receptors, but previous studies showed that receptors 
and downstream signaling components in TGF-β signaling 
are enriched in primary cilia and at the ciliary base region 
[28]. In fibroblasts, TGF-β1 stimulation leads to a trans-
location of TGF-β receptors from the cilium to the ciliary 
pocket, for clathrin-mediated endocytosis of the activated 
TGF-β receptors, and phosphorylation of SMAD2/3 in early 
endosomes at the ciliary base region [28] (Fig. 7). Since 
TSC1 contains a putative transmembrane domain [73] and 
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localizes to the ciliary base in human RPE cells [43] and 
early endosomes in HeLa cells [11], TSC1 may function 
at the primary cilium to regulate TGF-β receptor-mediated 
activation of SMAD2/3, although speculative at this point.
TGF-β-SMAD2/3 signaling has previously been associ-
ated with TSC as the expression of TGF-β ligand is upregu-
lated in angiofibromas obtained from TSC patients [74]. 
However, the genotype of the TSC patients examined in 
this study was not specified. Furthermore, TGF-β activates 
mTORC1 in murine fibroblasts but not in epithelial cells 
via a PI3 K/AKT/TSC2-dependent pathway [75]. It remains 
to be investigated whether this effect on mTOR activity is 
compromised only in Tsc2−/− MEFs.
Since TGF-β and HH signaling converge at the level 
of GLI2, we further elaborated on the link between low 
Gli2 expression and the observed elongated ciliary length 
phenotype in Tsc1−/− MEFs. TGF-β1-driven Gli2 expres-
sion contributes to canonical HH signaling, but Gli2 may 
also regulate target gene expression downstream of TGF-β 
signaling, including expression of genes encoding mem-
bers of the WNT protein family [68]. In the canonical WNT 
pathway, binding of WNT ligands to Frizzled receptors 
induces β-catenin stabilization and entry into the nucleus 
to regulate target gene transcription. However, the so-called 
non-canonical WNT proteins, such as WNT5A [76], are 
involved in alternate signaling cascades including a role in 
WNT5A-PLK1-dependent stimulation of Aurora A kinase, 
leading to the disassembly of the primary cilium [69]. We 
here demonstrate that a low Gli2 mRNA level correlated 
with reduced Wnt5a expression, which in turn contributes 
to an elongated ciliary length phenotype. The cilia length in 
the Tsc1−/− cells was reduced by both recombinant WNT5A 
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Fig. 7  Model illustrating the effect of TSC1 on HH signaling, cili-
ogenesis and cilia disassembly. 1: TGF-β receptors (TGF-β-RI and 
TGF-β-RII) localize to the ciliary tip. 2: TGF-β1 stimulation leads 
to heterotetramerization of the receptors and activation by phospho-
rylation of SMAD2/3 at the ciliary base. 3: TSC1 is required for this 
step. 4: phosphorylated SMAD2/3 (pSMAD2/3) acts (in a trimeric 
complex with SMAD4) as transcription factor leading to expression 
of Gli2. 5: GLI2 is translocated to the cilium where it is inhibited by 
SUFU (negative regulator of HH). 6: inactive SMO is activated by 
its agonist purmorphamine. 7: activation of SMO leads to removal 
of SUFU followed by expression of Gli2. 8: active GLI2 enters the 
nucleus as a transcription factor leading to expression of Gli1 and 
Wnt5a. 9: WNT5A mediates primary cilia disassembly. 10: Tsc2-defi-
cient cells display shortened primary cilia. 11: the TSC1/TSC2 com-
plex downregulates mTORC1, leading to increased autophagy. 12: 
during starvation AMPK promotes autophagy directly and indirectly 
through phosphorylation of TSC2, which then inhibit mTORC1. 
13: Tsc1-deficient cells display increased mTORC1 activity but at 
the same time mTORC1-dependent increased autophagic flux. 14: 
autophagic activity stimulates ciliogenesis
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and by rapamycin treatment. Whereas reduced expression 
of Wnt5a could be explained by aberrant TGF-β-SMAD2/3 
signaling, the effect of rapamycin could be explained by 
mTORC1-dependent increased autophagic flux in the 
Tsc1−/− MEFs. However, we cannot exclude the possibility 
that rapamycin treatment also leads to even shorter cilia in 
Tsc2−/− cells, as the cilia are already very short and difficult 
to measure by our microscopy setup.
In summary, we have demonstrated that loss of TSC1 
causes both increased autophagic flux and impaired SMO-
dependent HH signaling due to reduced expression of 
Gli2. The long cilia phenotype in Tsc1−/− MEFs could be 
explained by a combination of increased cilia growth due to 
increased autophagic flux and reduced rate of disassembly 
due to reduced expression of the transcription factor Gli2 
that regulates the expression of Wnt5a (Fig. 7). Although 
substantial progress has been made in understanding the 
role of the heterodimeric complex formed by the proteins 
encoded by TSC1 and TSC2 in TSC pathology, many ques-
tions remain regarding the separate functions of these two 
genes. Addressing these questions in the future will contrib-
ute to a better understanding of the molecular etiology of 
TSC and potential new opportunities for therapy.
Materials and methods
Cell cultures and reagents
All mouse embryonic fibroblast cells were obtained from 
D. Kwiatkowski, Harvard University, Boston, MA, USA. 
They were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with Glutamax, 10% Fetal Bovine 
Serum (FBS), 1% penicillin–streptomycin. The cells were 
grown in a 5%  CO2 incubator at 37 °C. To induce ciliary 
formation cells were starved (0.5% FBS) for 48 h, and to 
measure autophagic flux cells were cultured in the presence 
and in the absence of rapamycin before lysosomal degrada-
tion was inhibited by 20 mM ammonium chloride  (NH4Cl, 
Sigma-Aldrich #A-0171) and 200 µm Leupeptin (Biovi-
sion #1648) for 2 or 4 h. Cells were treated with 25 nM 
rapamycin (Cell Signaling Technology #9904) for 48 h to 
inhibit mTORC1 activity and 5 µM purmorphamine (Santa 
Cruz biotechnologies #sc-202785) for 24 h to activate HH 
signaling (last 24 h of the 48 h in starvation medium). To 
induce autophagy, cells were further incubated with 10 µM 
ABT-737 (Selleckchem # S1002) for 24 h. SMAD2/3 sign-
aling was stimulated with 2 ng ml−1 recombinant human 
TGF-β1 (R&D Biosystems #240-B) and inhibited with 
10 μM SB431542 (InvivoGen #inh-sb43) for indicated time 
points. Recombinant human/mouse WNT5a (fragment Gln-
38Lys380, which is identical in mouse and human expressed 
in Chinese Hamster Ovary cell line, R&D Biosystems 
#645-WN) was administered to the cells at 300 nM for 24 h 
prior to induction of ciliary formation in starvation medium 
(0.5% FBS). Primary antibodies used for IFM were as fol-
lows (dilutions, vendor and catalog number in parenthesis): 
mouse anti-acetylated α tubulin (1:2000, Sigma-Aldrich 
#T6793), rabbit anti-α-tubulin (1:1000, Sigma-Aldrich 
#T5192), rabbit anti-KI67 (1:250, Abcam #ab15580), rab-
bit anti-IFT88 (1:1000, Nordic Biosite/Proteintech, 13967-
1-ap). Secondary antibodies used were Alexa fluor 546 
donkey anti-mouse IgG (1:1000, Invitrogen # A10036) 
and Alexa fluor 488 goat anti-rabbit IgG(1:1000, Invitro-
gen # A11008). Dnase I (Invitrogen, 18068015) was used 
for degradation of plasmids present in RNA samples. The 
following primary antibodies were used for WB analysis 
(dilutions, vendor and catalog number in parenthesis): rabbit 
anti-phospho-S6 Ribosomal Protein (1:1000, Cell Signaling 
# 4858), rabbit anti-GAPDH (1:5000, Cell Signaling #2118), 
rabbit anti-total-S6 Ribosomal Protein (1:1000, Cell Sign-
aling #2217), rabbit anti-TSC1 (1:500, Abcam #ab25882), 
rabbit anti-TSC2 (1:1000, Cell Signaling #4308), rabbit 
anti-phospho-SMAD2 (1:1000 Cell Signaling #3101), rab-
bit anti-total-SMAD2 (1:1000 Cell Signaling #5339), goat 
anti GLI2 antibody (1:1000 R&D system AF3635-SP), goat 
anti-GLI3 (1:1000 R&D system AF3690-SP) rabbit anti 
Lamin A antibody (1:1000, abcam ab26300), mouse anti-
α-tubulin (1:5000, Sigma-Aldrich #T6199) and rabbit anti 
LC3B (1:250, Sigma-Aldrich #L7543. Secondary antibodies 
used were HRP-conjugated goat anti-mouse IgG (1:2000, 
DAKO, # P0447), HRP-conjugated Swine anti-rabbit IgG 
(1:2000, DAKO, # P0399) and HRP-conjugated rabbit anti-
goat IgG (1:2000, DAKO, #Pol60).
Immunofluorescence microscopy (IFM) and imaging 
analysis
Approximately 0.5 × 106 cells per well were seeded in a 
6-well plate containing glass coverslips and allowed to incu-
bate in complete medium (DMEM containing 10% FBS, 1% 
penicillin–streptomycin) for 24 h prior to cilia induction by 
culturing cells in starvation medium (0.5% FBS) for 48 h 
followed by three times washing in ice-cold phosphate-
buffered saline (PBS). They were then fixed in 4% para-
formaldehyde for 15 min, washed three times in PBS, per-
meabilized with 1% Triton-X-100 in PBS for 15 min, and 
incubated in blocking solution [PBS containing 3% bovine 
serum albumin (BSA)] for 30 min. The cells were incubated 
with primary antibodies overnight at 4 °C and washed three 
times in blocking solution. Secondary antibodies were 
added for 45 min at room temperature followed by washing 
for 5 min in blocking solution. They were then incubated 
with 0.5 μg ml−1 4′, 6-diamidino-2-phenylindole for 30 s to 
stain DNA, washed three times in PBS and mounted with 
an anti-fading mounting gel containing N-propyl gallate 
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(Sigma-Aldrich #P3130). All procedures were performed 
at room temperature. Confocal microscopy was performed 
using an Olympus Fluoview 1000 FV. Adjustments to 
brightness and contrast were minimal and applied to the 
whole image. Z-stacked images were Z-projected and Fiji 
software (http://fiji.sc) was used for measuring cilia length.
SDS‑PAGE and WB analyses
The cells were lysed with ice-cold lysis buffer (50 mM 
Tris–HCl pH 6.8, 10% glycerol, 2.5% SDS, 10 mM DTE, 
10  mM β-glycerophosphate, 10  mM NaF, 0.1  mM Na-
orthovanadate, 1 mM phenylmethylsulfonyl fluoride and 
1×  complete protease inhibitor cocktail tablets (Roche 
#11697498001), vortexed for 10 s and left on ice for 30 min 
followed by 3 × 10 s. sonication, and centrifuged for 5 min 
at 13,000 rpm at 4 °C. Supernatant fractions were used for 
protein analysis. Total protein (20 μg) was separated by 
SDS-PAGE and transferred to nitrocellulose membranes. 
After applying blocking solution (100 mM Tris pH 7.6, 0.1% 
Tween 20, 5% dry milk) for 45 min at room temperature, 
the membranes were incubated with primary antibodies and 
left over night at 4 °C. They were then washed five times 
in TBS-T (100 mM Tris pH 7.6, 0.1% Tween 20), followed 
by incubation with HRP-conjugated secondary antibodies, 
which were detected with SuperSignal™ West Dura (Ther-
moFisher Scientific # 34076) and digitally developed by 
chemiluminescence using G:Box Chemi XX6 (Syngene). 
Where necessary, the membranes were stripped by two 
rinses in stripping solution (1% Tween 20, 0.1% SDS, 1.5% 
glycine, pH 2.2) followed by two rinses in PBS and TBS-T. 
The membranes were then ready to be blocked again. The 
optical density of the bands was analyzed with the gel ana-
lyzer of the Fiji software.
Plasmid transfection and siRNA‑mediated gene 
knock down
The following plasmids were used for transient plasmid 
transfection: GFP-tagged Gli2 (pGli2, mouse) (Addgene 
#37672), Myc-tagged human WT-TSC1, pTSC1 and human 
TSC2-Flag, pTSC2 (both a gift from Mark Nellist, Erasmus 
MC, Rotterdam). JetPRIME (Polyplus transfection, Illkirch, 
France) was used as the transfection reagent following the 
protocol provided by the manufacturer. RNA silencing was 
achieved using siRNA targeting mouse Tsc1 (#1: TTG GTT 
GAT TAT TAC CTG GAA #2: ATC GAG AAA GAT AAG 
GAA GAA), Tsc2 (#1: CAG CAT TAA TAT CTT ATC ACA 
#2: CTG GAC ATC ATT GAA CGA CTA), Wnt5a (AAG 
ATC TTA AAT ATA GAT ATA) and Gli2 (CAC CAA CCC 
TTC AGA CTA TTA) or a scramble sequence for control at 
a final concentration of 25 nM. All siRNAs were from Qia-
gen and delivered to cells using DharmaFECT1 transfection 
reagent (Dharmacon), following the protocol provided by 
the manufacturers.
Quantitative RT‑PCR analysis (qPCR)
For cDNA preparation total RNA was extracted from the 
cell cultures using the RNeasy Mini kit (Qiagen) follow-
ing the instructions provided by the manufacturer. To vali-
date the transfection efficiency with plasmids (p.TSC1, 
p.TSC2, p.Gli2), an isolated RNA was treated with DNase I 
(11284932001 Roche) before cDNA preparation according 
to the manufacturer’s protocol. An empty p.cDNA3 vec-
tor was used for Mock transfection. The RNA concentra-
tion was determined using a NanoDrop Spectrophotometer 
(Thermo Fisher Scientific). For cDNA preparation, reverse 
transcription was carried out using the High-Capacity cDNA 
Reverse Transcription Kit (Thermo Fisher Scientific). Stand-
ard qPCR was carried using predesigned TaqMan probes 
(Thermo Fisher Scientific) targeting the gene of interest. 
The measurements are performed in triplicates. The expres-
sion levels were normalized to the level of TATA binding 
protein (TBP) in the same samples after amplification with 
the TaqMan Gene Expression Master Mix (Thermo Fisher 
Scientific) on a 7500 Real-Time PCR system (Applied Bio-
systems) and the − ΔΔCt method was used to evaluate dif-
ferential expression [77]. The Ct value is the cycle number 
at which the fluorescence generated within a reaction crosses 
the threshold line. Ct levels are inversely proportional to 
the amount of target in the sample, the lower the Ct level 
the greater the amount of target. ΔCt is the difference in Ct 
values for our target gene and our housekeeping gene (Tbp) 
for a given sample (normalized values) and ΔΔCt is the dif-
ference in ΔCt values between treated and untreated samples 
[77]. The negative value − ΔΔCt, is used as the exponent 
of 2 in the equation 2−ΔΔCt and represents the difference in 
normalized number of Ct values. The exponent 2 is used 
based on the assumption that each cycle doubles the amount 
of product. If the control sample ΔCt is 4 and the treated 
sample ΔCt is 2, then 2−ΔΔCt  (2−(2–4)) yields 4, meaning that 
the gene of interest in the treated sample is increased four 
times in comparison to the control sample.
Cellular fractionation
Cellular fractionation was performed as described previ-
ously [78].
Statistical analysis
Quantitative results represent the mean of at least three 
independent experiments, if not specified otherwise. Error 
bars represent standard error of the mean (SEM, n ≥ 3). 
p values were calculated using Student’s t test, if not 
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specified otherwise. *p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001). ¤: borderline value p = 0.055.
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